Showing posts with label Germany. Show all posts
Showing posts with label Germany. Show all posts

Monday, 19 April 2021

Learning to breathe: German clinic helps Covid long haulers

‘Located in Heiligendamm, a north German seaside spa popular since the late 18th century, the clinic specializes in helping people with lung diseases such as asthma, chronic bronchitis and cancer. Over the past year it has become a major rehabilitation center for COVID-19 patients, treating 600 people from across Germany, according to its medical director, Dr. Joerdis Frommhold.

‘Some of her patients came close to death and now have to relearn how to breathe properly, rebuild their stamina and overcome a host of neurological problems associated with severe illness. But Frommhold also treats a second group of patients who experienced mild to medium COVID-19 symptoms, and only spent a short time in the hospital, if at all. “These patients get rebound symptoms after about one to four months,” Frommhold said.

Read here (Associated Press, Apr 20, 2021) 

Monday, 15 March 2021

BioNTech and Fosun Pharma form Covid-19 vaccine strategic alliance in China

  • BioNTech and Fosun Pharma will jointly conduct clinical trials of BNT162 in China, leveraging BioNTech’s proprietary mRNA vaccine technology and Fosun Pharma’s clinical development and commercialization capabilities in China
  • Fosun Pharma will commercialize the vaccine in China upon regulatory approval, with BioNTech retaining full rights to develop and commercialize the vaccine in the rest of the world
  • Fosun Pharma will pay BioNTech up to USD 135M (EUR 120M) in upfront and potential future investment and milestone payments; the two companies will share future gross profits from the sale of the vaccine in China

Read here (BioNTech press statement, Mar 16, 2021)

Thursday, 4 March 2021

Germany approves AstraZeneca vaccine for over-65s

‘Germany's vaccine commission has approved the use of the Oxford-AstraZeneca jab in people aged over 65. The country previously approved it for under-65s only, citing insufficient data on its effects on older people. That led to public scepticism about its effectiveness, with some Germans spurning it and leaving many doses unused.

‘But German Chancellor Angela Merkel said recent studies had now provided enough data to approve it for all ages. Announcing the commission's decision on Thursday, Health Minister Jens Spahn said the move was "good news for older people who are waiting for an injection".’

Read here (BBC, Mar 5, 2021) 

Sunday, 21 February 2021

What Europeans have learned from a year of pandemic

‘From the first case diagnosed a year ago at a hospital in northern Italy to the empty shops, restaurants and stadiums of Europe's cities, the lives of Europeans have been changed forever. Curbs on movement have forced every country and society to adapt its rules and rethink its culture. There have been hard truths and unexpected innovations in a year that changed Europe.

  • Restrictions are tough for societies used to freedom
  • Experts are essential, but mistakes have been made
  • The EU wasn't set up for a pan-European health crisis
  • Societies have responded in different ways
  • A Europe without borders is fine in theory
  • Hard truths about how we slaughter animals
  • Europeans embraced lifestyle change in different ways

Read here (BBC, Feb 20, 2021)

Saturday, 13 February 2021

Germany: Ways out of the coronavirus crisis

‘Northeastern Germany has managed the crisis better than the rest of the country. As Rostock eases restrictions, it aims to be a model for other cities.’

View video here (DW, Feb 13, 2021) 

Thursday, 28 January 2021

German officials say AstraZeneca vaccine shouldn't be given to over-65s, citing lack of data

‘Germany's vaccine commission said the AstraZeneca coronavirus vaccine should not be given to people older than 65 years, amid a bitter dispute between the European Union and the drugmaker over delayed supplies.

‘The Standing Committee on Vaccination (STIKO) at Germany's Robert Koch Institute (RKI), the country's main public health authority, found there is insufficient data on the effectiveness of the vaccine, developed by AstraZeneca and the University of Oxford, for this age group, according to a statement from the interior ministry on Thursday. "Due to the small number of study participants in the age group ≥65 years, no conclusion can be made regarding efficacy and safety in the elderly. This vaccine is therefore currently recommended by STIKO only for persons aged 18-64 years," the panel said in its recommendation.’

Read here (CNN, Jan 28, 2021) 

Wednesday, 20 January 2021

Europe’s growing mask ask: Ditch the cloth ones for medical-grade coverings

‘Faced with new, more contagious, strains of the coronavirus and a winter surge in cases, European nations have begun to tighten mask regulations in the hope that they can slow the spread of the virus. Germany on Tuesday night made it mandatory for people riding on public transport or in supermarkets to wear medical style masks: either N95s, the Chinese or European equivalent KN95 or FFP2s, or a surgical mask.

‘It follows a stricter regulation from the German state of Bavaria this week that required N95 equivalents in stores and on public transport. Austria will introduce the same measures from Monday.’

Read here (Washington Post, Jan 20, 2021)

Sunday, 27 December 2020

German Covid-19 vaccination campaign overshadowed by mishaps

‘Germany's COVID-19 vaccination campaign has been overshadowed by an overdose mishap in the north and problems with the transportation of the vaccine in the south which lead to 1,000 shots being sent back.’

Read here (Reuters, Dec 28, 2020)

Tuesday, 29 September 2020

Germans embrace fresh air to ward off coronavirus

‘Ventilating rooms has been added to the German government’s formula for tackling coronavirus, in refreshing news for the country’s air hygiene experts who have been calling for it to become official for months. The custom is something of a national obsession, with many Germans habitually opening windows twice a day, even in winter. Often the requirement is included as a legally binding clause in rental agreements, mainly to protect against mould and bad smells. But while some people may dismiss the method as primitive, “it may be one of the cheapest and most effective ways” of containing the spread of the virus, Angela Merkel insisted on Tuesday.’

Read here (The Guardian, Sept 30, 2020) 

Thursday, 24 September 2020

Countries should meet these five criteria before easing lockdowns, study says. Many aren't even close

‘Countries should not ease coronavirus lockdown restrictions until they meet five criteria -- and many nations are not even close, according to a new analysis published in The Lancet medical journal. The research, published Thursday, said that the prerequisites for easing Covid-19 measures are: knowledge of infection status, community engagement, adequate public health capacity, adequate health system capacity and border controls.

‘The authors looked at nine high-income countries and territories that have started to relax restrictions -- Hong Kong, Japan, New Zealand, Singapore, South Korea, Germany, Norway, Spain and the UK. They found that many governments had failed to meet the criteria necessary to avoid new waves of infection, as seen in Spain, Germany and the UK.’

Read here (CNN, Sept 25, 2020)

Wednesday, 16 September 2020

For Covid-19, as with everything else, Americans on the right and left live in different universes when it comes to trusting the media

‘More in Common — a group that tries to “counter polarization” and “build bridges across dividing lines” — has a new report out this morning called “The New Normal,” which looks at “the impacts of COVID-19 on trust, social cohesion, democracy and expectations for an uncertain future.” It looks at seven countries (U.S., U.K., France, Germany, Italy, Poland, and the Netherlands) and is based on surveys of about 14,000 people.’

This story focuses on ‘how people in [the] seven countries view the motives of the news media in covering the pandemic. Only in the United States is that a profoundly partisan question.’

Read here (Nieman Lab, Sept 17, 2020)

Saturday, 25 July 2020

Governments losing support for their handling of Covid-19: Survey

‘Governments are fast losing support for their handling of the coronavirus outbreak from a public that widely believes death and infection figures to be higher than statistics show, a survey of six countries [US, Britain, France, Sweden, Japan and Germany] revealed on Saturday (July 25).’

Read here (Straits Times, July 25, 2020)

Sunday, 31 May 2020

Nobel laureate Michael Levitt on the lockdowns: “I think it is a huge mistake”

‘Q: What’s your view of the lockdown policy that so many European countries and states in America have introduced?

‘A: I think it is a huge mistake. I think we need smart lockdowns. If we were to do this again, we would probably insist on face masks, hand sanitizers, and some kind of payment that did not involve touching right from the very beginning. This would slow down new outbreaks and I think that for example they found as I understand, that children, even if they’re infected, never infect adults, so why do we not have children at school? Why do we not have people working? England, France, Italy, Sweden, Belgium, Holland, are all reaching levels of saturation that are going to be very, very close to herd immunity — So that’s a good thing. I think the policy of herd immunity is the right policy. I think Britain was on exactly the right track — before they were fed wrong numbers and they made a huge mistake.’

Read here (AIER, May 31, 2020)

Thursday, 21 May 2020

Will coronavirus change Germans’ love of cash?

“Covid-19 has probably changed German payment behaviour faster than any single technology ever has,” says Georg Hauer, general manager of the Germany-Austria-Switzerland region at N26, a Berlin-based online banking start-up. For many Germans, using cash isn't just a personal preference; it's a cultural value that they've grown up with — and one tied closely to a national value with centuries-old roots.

Read here (BBC, May 21, 2020)

Tuesday, 5 May 2020

As some countries ease up, others are reimposing lockdowns amid a resurgence of coronavirus infections

As many parts of the world, including the United States, explore ways to ease restrictions aimed at containing the spread of the coronavirus, countries that had already opened up are closing down again after renewed spikes in infections. [Lebanon, South Korea, China, Iran, Germany]

Such a resurgence of cases had been widely predicted by experts, but these increasing numbers come as a sobering reminder of the challenges ahead as countries chafing under the social and economic burdens of keeping their citizens indoors weigh the pros and cons of allowing people to move around again.

Read here (Washington Post, May 5, 2020)

Tuesday, 28 April 2020

Germany's Covid-19 infection rate rises after lockdown lifted

‘The rate at which the coronavirus is spreading in Germany has increased following the easing of lockdown restrictions. Authorities say the “R” factor, which measures the average number of people that an infected person contaminates, is now close to the limit of target levels. It had been at around 0.7 on April 20th when Germany eased restrictions on movement and economic activity. Now it is at 0.96, said Lothar Wieler, the head of the Robert Koch Institute.’

Read here (Euronews, April 28, 2020)

Thursday, 16 April 2020

Twelve lessons from countries that have ameliorated the effects of Covid-19

Taiwan, Iceland, South Korea and Germany, according to this CNN article, have succeeded so far in ameliorating the effects of Covid-19. There are 12 lessons to be learned from them:

Lesson #1: Be prepared
Lesson #2: Be quick
Lesson #3: Test, trace and quarantine
Lesson #4: Use data and tech
Lesson #5: Be aggressive
Lesson #6: Get the private sector involved 
Lesson #7: Act preventatively
Lesson #8: Use tech, but respect privacy
Lesson #9: You can drive-through test
Lesson #10: Learn from the past
Lesson #11: Test more as restrictions ease
Lesson #12: Build capacity at hospitals

Read here (CNN, April 16, 2020)

Sunday, 5 April 2020

Decentralisation is helping Germany beat Covid-19

‘German public health services are provided not by one central authority but by approximately 400 public health offices, run by municipality and rural district administrations.

‘Such an environment allows for a variety of laboratories – some attached to universities or hospitals, others privately run, medium-sized businesses – which act largely autonomously of central control.’

Read here (The Guardian, April 5, 2020)

Wednesday, 25 March 2020

Nurses. Nurses. Nurses

“Among the nine countries with the highest number of Covid-19 cases, the country that has the highest nurse rate also has the lowest death rate from the disease. Germany has 13.2 nurses per 1,000 (echoing a trend for high nurse numbers throughout Northern Europe) far above the other heavily Covid-19 affected countries.

“This may be just another armchair epidemiologist observation of course. But higher numbers of nurses may reflect one of two beneficial factors (or both): first, that nurses, the backbone of hospital (and especially ICU) care, are essential to patient management and, ultimately, survival.

“The second is that the sort of hospital or country that knows the value of nurses also is a hospital or country that understands how to deliver effective health care and has likely made countless other unmeasured adjustments to improve quality.”

Read here (CNN, March 25, 2020)

Worst ever Covid variant? Omicron

John Campbell shares his findings on Omicron.  View here (Youtube, Nov 27, 2021)